Synthesis and Electrophilic Substitution of 1-Methyl-, 1,2-Dimethyl-, and 1-Methyl-2-phenyl-2H-cyclopentapyridazines

DOI: 10.1021/jo00199a005

Source and publish data:

Journal of Organic Chemistry p. 4769 - 4772 (1984)

Update date:2022-08-02

Topics:

Authors:

Anderson, Arthur G.

Ko, Ronald P.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/jo00199a005

1-Methyl- (2), 1,2-dimethyl- (3), and 1-methyl-2-phenyl-2H-cyclopentapyridazines(4) were prepared from 2-acetyl-6-(dimethylamino)fulvene (1) and their structures established with the aid of T₁ NMR and X-ray analysis.The relative chemical shi

Full text of DOI:10.1021/jo00199a005

Products guided by the article

Product name:2H-Cyclopenta[d]pyridazine, 1-methyl-2-phenyl-

Cas No:92671-45-9

R&D Labs maybe for 92671-45-9

Jintan Jinnuo Chemical Co., Ltd.

Contact:+86-519-80199901

Address:Room 1804, Building 1, Huacheng Business Plaza, Jintan, Jiangsu, China
TIANJIN FESTO CHEMICAL CO.,LTD(expird)

Contact:86-22-25814570

Address:No.12th,5th Ave.,TEDA,Tianjin,China
Dalian RSD International Trade Co.,Ltd.(expird)

Contact:86-22-60875058 58610575

Address:Wantong International Areas, Hongqiao District, Tianjin, China.China
EAST CHEMSOURCES LIMITED

website:http://www.eastchem-cn.com

Contact:15053231572

Address:No.1581-12,Jinshui Road, Licang, Qingdao,China

Relevant to this article

Polysubstituted pyridazinones from sequential nucleophilic substitution reactions of tetrafluoropyridazine

Doi:10.1021/jo9006943
(2009)
2-Cyclohexylcarbonylbenzimidazoles as potent, orally available and brain-penetrable opioid receptor-like 1 (ORL1) antagonists

Doi:10.1016/j.bmcl.2009.04.023
(2009)
Lewis base directed cycloaddition reactions of 2-pyrones and alkynylaluminum reagents

Doi:10.1021/ol401952k
(2013)
Aryl sulfonamido tetralin inhibitors of the Kv1.5 ion channel

Doi:10.1016/j.bmcl.2009.04.002
(2009)
CaCl₂- or MgCl₂-catalyzed allylic oxidations of ionone-like dienes

Doi:10.1055/s-2006-951476
(2006)
The identification of novel orally active mGluR5 antagonist GSK2210875

Doi:10.1016/j.bmcl.2010.09.120
(2010)

Article Doi